Michael Bleavins is a seasoned drug development and biomarker consultant with extensive experience spanning over three decades in the biotechnology and pharmacology sectors. Currently serving at White Crow Innovation since August 2006, Michael assists various clients in advancing the development of new therapeutic compounds across multiple indications including oncology, inflammation, and cardiovascular diseases. In academia, Michael has held adjunct faculty positions at Wayne State University and the University of Michigan since 1996, focusing on topics such as translational pharmacology and drug development. Additionally, Michael founded the Michigan Technology and Research Institute and MitriGene, both of which provide consulting and biomarker services. Previous roles include leadership positions at Pfizer and Parke-Davis, complemented by a robust educational background in toxicology and natural sciences with degrees from Michigan State University and Wayne State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices